Sha Yi

1.2k total citations
56 papers, 810 citations indexed

About

Sha Yi is a scholar working on Molecular Biology, Plant Science and Cancer Research. According to data from OpenAlex, Sha Yi has authored 56 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 10 papers in Plant Science and 7 papers in Cancer Research. Recurrent topics in Sha Yi's work include Natural product bioactivities and synthesis (13 papers), Phytochemistry and Biological Activities (7 papers) and Biological Activity of Diterpenoids and Biflavonoids (5 papers). Sha Yi is often cited by papers focused on Natural product bioactivities and synthesis (13 papers), Phytochemistry and Biological Activities (7 papers) and Biological Activity of Diterpenoids and Biflavonoids (5 papers). Sha Yi collaborates with scholars based in China, United States and Japan. Sha Yi's co-authors include Xian Li, Lijing Yang, Shuang Cai, Taoguang Huo, Mingyang Yu, Guohui Cui, Famei Li, Xiumei Lu, Lubing Gu and Hailong Zhang and has published in prestigious journals such as Water Research, Cancer Cell and Free Radical Biology and Medicine.

In The Last Decade

Sha Yi

51 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sha Yi China 17 540 165 90 81 66 56 810
Mei-Due Yang Taiwan 17 344 0.6× 163 1.0× 80 0.9× 58 0.7× 89 1.3× 26 792
Keishi Hata Japan 18 556 1.0× 114 0.7× 123 1.4× 58 0.7× 68 1.0× 62 1.1k
Karina Bettega Felipe Brazil 16 407 0.8× 167 1.0× 59 0.7× 112 1.4× 57 0.9× 37 892
Valeria Naponelli Italy 20 529 1.0× 200 1.2× 104 1.2× 101 1.2× 68 1.0× 35 1.2k
Zeyun Li China 18 482 0.9× 213 1.3× 63 0.7× 47 0.6× 114 1.7× 47 843
Iqra Sarfraz Pakistan 14 398 0.7× 130 0.8× 53 0.6× 47 0.6× 114 1.7× 23 816
Nevena Grdović Serbia 19 348 0.6× 116 0.7× 80 0.9× 44 0.5× 43 0.7× 67 909
Lingyu Li China 17 377 0.7× 277 1.7× 92 1.0× 51 0.6× 89 1.3× 58 915
Antonio J. León‐González Spain 18 559 1.0× 205 1.2× 73 0.8× 40 0.5× 126 1.9× 38 1.2k
Sunmi Kang South Korea 14 470 0.9× 138 0.8× 42 0.5× 51 0.6× 55 0.8× 27 710

Countries citing papers authored by Sha Yi

Since Specialization
Citations

This map shows the geographic impact of Sha Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sha Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sha Yi more than expected).

Fields of papers citing papers by Sha Yi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sha Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sha Yi. The network helps show where Sha Yi may publish in the future.

Co-authorship network of co-authors of Sha Yi

This figure shows the co-authorship network connecting the top 25 collaborators of Sha Yi. A scholar is included among the top collaborators of Sha Yi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sha Yi. Sha Yi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Postlewait, Lauren M., Yi Liu, Stephanie Jou, et al.. (2024). Changes in expression of breast cancer tumor biomarkers between primary tumors and corresponding metastatic sites: common patterns and relationships with survival. Breast Cancer Research and Treatment. 207(2). 373–382. 2 indexed citations
4.
Chen, Yan, Sha Yi, Qing Wang, et al.. (2023). Lutein attenuates Propionibacterium acnes-induced inflammation by inhibiting pyroptosis of human keratinocyte cells via TLR4/NLRP3/Caspase-1 pathway. International Immunopharmacology. 117. 109937–109937. 5 indexed citations
5.
Gu, Lubing, Hailong Zhang, Tao Liu, et al.. (2017). Inhibition of MDM2 by a Rhein-Derived Compound AQ-101 Suppresses Cancer Development in SCID Mice. Molecular Cancer Therapeutics. 17(2). 497–507. 24 indexed citations
6.
Yi, Sha, et al.. (2017). Research on FAST Node Displacement Prediction Based on ELM Neural Network. Journal of Northeastern University. 38(5). 630. 1 indexed citations
7.
Zhang, Xia, Sha Yi, Lu Wen, et al.. (2017). Deguelin induced differentiation of mutated NPM1 acute myeloid leukemia in vivo and in vitro. Anti-Cancer Drugs. 28(7). 723–738. 8 indexed citations
8.
Zhang, Xia, Lu Wen, Sha Yi, et al.. (2016). Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation. European Journal of Pharmacology. 789. 46–59. 10 indexed citations
9.
Wen, Lu, Yan Chen, Ling Zeng, et al.. (2015). Triptolide Induces Cell Apoptosis by Targeting H3K4me3 and Downstream Effector Proteins in KM3 Multiple Myeloma Cells. Current Pharmaceutical Biotechnology. 17(2). 147–160. 8 indexed citations
10.
Liu, Tao, Hailong Zhang, Jing Xiong, et al.. (2015). Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival. Molecular Cancer. 14(1). 65–65. 23 indexed citations
11.
Li, Feifei, Sha Yi, Lu Wen, et al.. (2014). Oridonin induces NPM mutant protein translocation and apoptosis in NPM1c+ acute myeloid leukemia cells in vitro. Acta Pharmacologica Sinica. 35(6). 806–813. 31 indexed citations
12.
Wang, You, Sha Yi, Lu Wen, et al.. (2014). Nontoxic-dose of Deguelin Induce NPMc+ AML Cell Differentiation by Selectively Targeting Mt NPM1/SIRT1 Instead of HDAC1/3. Current Cancer Drug Targets. 14(8). 685–699. 7 indexed citations
13.
Yang, Lijing, Yan Chen, Jing He, et al.. (2012). Betulinic acid inhibits autophagic flux and induces apoptosis in human multiple myeloma cells in vitro. Acta Pharmacologica Sinica. 33(12). 1542–1548. 32 indexed citations
14.
Chen, Gang, Sha Yi, Huiming Hua, Xuan Lu, & Yue‐Hu Pei. (2012). Two new steroidal glycosides fromCynanchum amplexicaule. Journal of Asian Natural Products Research. 14(6). 559–563. 4 indexed citations
15.
Yang, Lijing, Yan Chen, Jing He, et al.. (2012). Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via the accumulation of ROS. Oncology Letters. 3(5). 1159–1165. 36 indexed citations
16.
He, Jing, Peng Jin, Yan Chen, et al.. (2011). The time-dependent autophagy protects against apoptosis with possible involvement of Sirt1 protein in multiple myeloma under nutrient depletion. Annals of Hematology. 91(3). 407–417. 26 indexed citations
17.
Li, Zhan‐Lin, et al.. (2007). Three Novel Sterols Isolated from Selaginella tamariscina with Antiproliferative Activity in Leukemia Cells. Planta Medica. 73(10). 1112–1115. 26 indexed citations
18.
Sun, Kai, Xian Li, Wen Li, et al.. (2006). A new nor-lignan from the seeds ofDescurainia sophia. Natural Product Research. 20(6). 519–522. 23 indexed citations
19.
Guo, Yuanqiang, Xian Li, Jinhui Wang, Wen Li, & Sha Yi. (2003). A new sesquiterpene ester from the fruits ofCelastrus orbiculatus. Journal of Asian Natural Products Research. 5(3). 205–208. 8 indexed citations
20.
Yi, Sha, et al.. (2001). Studies on chemical constituents of ixeris sonchifolia. Zhongcaoyao. 32(2). 97–99. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026